These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1400876)

  • 1. Spontaneous and stimulated growth hormone release in adolescents with type I diabetes mellitus: effects of metabolic control.
    Miller JD; Wright NM; Lester SE; Felsing NE; Linzer J; Chan E; White DA; Charles MA
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1087-91. PubMed ID: 1400876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus.
    Asplin CM; Faria AC; Carlsen EC; Vaccaro VA; Barr RE; Iranmanesh A; Lee MM; Veldhuis JD; Evans WS
    J Clin Endocrinol Metab; 1989 Aug; 69(2):239-45. PubMed ID: 2753972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.
    Salgado LR; Semer M; Nery M; Knoepfelmacher M; Lerário AC; Póvoa G; Jana S; Villares SM; Wajchenberg BL; Liberman B; Nicolau W
    J Endocrinol Invest; 1996; 19(7):433-40. PubMed ID: 8884537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
    Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes.
    Batch JA; Werther GA
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):411-6. PubMed ID: 1424174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus.
    Nieves-Rivera F; Rogol AD; Veldhuis JD; Branscom DK; Martha PM; Clarke WL
    J Clin Endocrinol Metab; 1993 Sep; 77(3):638-43. PubMed ID: 8370685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I).
    Cheetham TD; Connors M; Clayton K; Watts A; Dunger DB
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):415-24. PubMed ID: 9196603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
    Pal BR; Matthews DR; Edge JA; Mullis PE; Hindmarsh PC; Dunger DB
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):93-100. PubMed ID: 8435890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):149-57. PubMed ID: 8094648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous pulsatile growth hormone release in male and female premature infants.
    Miller JD; Wright NM; Esparza A; Jansons R; Yang HC; Hahn H; Mosier HD
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1508-13. PubMed ID: 1464656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of growth hormone secretion during puberty: evidence for a pulse amplitude-modulated phenomenon.
    Mauras N; Blizzard RM; Link K; Johnson ML; Rogol AD; Veldhuis JD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):596-601. PubMed ID: 3493255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone in type I diabetic and healthy man.
    Schaper NC
    Acta Endocrinol (Copenh); 1990; 122 Suppl 2():1-47. PubMed ID: 2110412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
    Giustina A; Bossoni S; Bodini C; Cimino A; Pizzocolo G; Schettino M; Wehrenberg WB
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
    Cheetham TD; Clayton KL; Taylor AM; Holly J; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):515-22. PubMed ID: 8187319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat.
    Miell J; Corder R; Miell PJ; McClean C; Gaillard RC
    J Endocrinol; 1991 Oct; 131(1):75-86. PubMed ID: 1683888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Giustina A; Bossoni S; Cimino A; Pizzocolo G; Romanelli G; Wehrenberg WB
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1486-90. PubMed ID: 2229305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced growth hormone responses to growth hormone releasing hormone in male type I diabetic patients.
    Pietschmann P; Schernthaner G; Stephenson J; Lang I; Templ H
    Horm Metab Res; 1991 Aug; 23(8):379-82. PubMed ID: 1794841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.